Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH

Molecular Cancer

Volumn 4, Issue , 2005, Pages

  Kresse, Stine H ^a,b   Berner, Jeanne Marie ^a   Meza Zepeda, Leonardo A ^a   Gregory, Simon G ^c   Kuo, Wen Lin ^d   Gray, Joe W ^d   Forus, Anne ^a   Myklebost, Ola ^a,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; APOLIPOPROTEIN A2; COMPLEMENTARY DNA; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 78; PHOSPHATASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; CANCER GROWTH; CELL GROWTH; CHROMOSOME 1Q; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; ENZYME SPECIFICITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA; SOUTHERN BLOTTING;

APOLIPOPROTEIN A-II; CHROMOSOMES, HUMAN, PAIR 1; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYSICAL CHROMOSOME MAPPING; RNA, MESSENGER; SARCOMA;

EID: 27944448457     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-4-39     Document Type: Article

References (46)

1. Schutte BC, Carpten JD, Forus A, Gregory SG, Horii A, White PS: Report and abstracts of the sixth international workshop on human chromosome 1 mapping 2000. Cytogenet Cell Genet 2001, 92:23-48.
2. Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara S, Tukiainen E, Elomaa I, Knuutila S: Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 1996, 15:89-94.
3. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, van Kessel AG: Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 1995, 14:8-14.
4. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O, van Kessel AG: Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer 1995, 14:15-21.
5. Enzinger FM, Weiss SW: Soft tissue tumors. 3rd edn. St. Louis: Mosby; 1995.
6. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992, 358:80-83.
7. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT: Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 1993, 53:5535-5541.
8. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, Sheng Z, Lau JW, Johnson PJ: Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 1999, 154:37-43.
9. Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC: Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 1999, 29:1208-1214.
10. Gronwald J, Storkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T: Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 1997, 57:481-487.
11. Qin LX, Tang ZY, Sham JS, Ma ZC, Ye SL, Zhou XD, Wu ZQ, Trent JM, Guan XY: The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res 1999, 59:5662-5665.
12. Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, Kellokumpu-Lehtinen P, Bohling T, Valle J, Knuutila S: DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 1999, 84:114-121.
13. Hirai M, Yoshida S, Kashiwagi H, Kawamura T, Ishikawa T, Kaneko M, Ohkawa H, Nakagawara A, Miwa M, Uchida K: 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment. Genes Chromosomes Cancer 1999, 25:261-269.
14. Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, Michiels JF, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C: Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999, 24:30-41.
15. Larramendy ML, Virolainen M, Tukiainen E, Elomaa I, Knuutila S: Chromosome band 1q21 is recurrently gained in desmoid tumors. Genes Chromosomes Cancer 1998, 23:183-186.
16. Forus A, Berner JM, Meza-Zepeda LA, Saeter G, Mischke D, Fodstad O, Myklebost O: Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas. Br J Cancer 1998, 78:495-503.
17. Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, Marenholz I, Lioumi M, Florenes VA, Maelandsmo GM, et al: Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene 2002, 21:2261-2269.
18. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, Cox T, Cuff J, Curwen V, Down T, et al: The Ensembl genome database project. Nucleic Acids Res 2002, 30:38-41.
19. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D: The human genome browser at UCSC. Genome Res 2002, 12:996-1006.
20. Brazma A, Parkinson H, Sarkans U, Shojatalab M, Vilo J, Abeygunawardena N, Holloway E, Kapushesky M, Kemmeren P, Lara GG, et al: ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 2003, 31:68-71.
21. Fauman EB, Saper MA: Structure and function of the protein tyrosine phosphatases. Trends Biochem Sci 1996, 21:413-417.
22. Park HD, Beeser AE, Clancy MJ, Cooper TG: The S. cerevisiae nitrogen starvation-induced Yvh1p and Ptp2p phosphatases play a role in control of sporulation. Yeast 1996, 12:1135-1151.
23. Guan K, Hakes DJ, Wang Y, Park HD, Cooper TG, Dixon JE: A yeast protein phosphatase related to the vaccinia virus VH1 phosphatase is induced by nitrogen starvation. Proc Natl Acad Sci U S A 1992, 89:12175-12179.
24. Hanaoka N, Umeyama T, Ueno K, Ueda K, Beppu T, Fugo H, Uehara Y, Niimi M: A putative dual-specific protein phosphatase encoded by YVH1 controls growth, filamentation and virulence in Candida albicans. Microbiology 2005, 151:2223-2232.
25. Muda M, Manning ER, Orth K, Dixon JE: Identification of the human YVH1 protein-tyrosine phosphatase orthologue reveals a novel zinc binding domain essential for in vivo function. J Biol Chem 1999, 274:23991-23995.
26. Sakumoto N, Yamashita H, Mukai Y, Kaneko Y, Harashima S: Dual-specificity protein phosphatase Yvh1p, which is required for vegetative growth and sporulation, interacts with yeast pescadillo homolog in Saccharomyces cerevisiae. Biochem Biophys Res Commun 2001, 289:608-615.
27. Kumar R, Musiyenko A, Cioffi E, Oldenburg A, Adams B, Bitko V, Krishna SS, Barik S: A zinc-binding dual-specificity YVH1 phosphatase in the malaria parasite, Plasmodium falciparum, and its interaction with the nuclear protein, pescadillo. Mol Biochem Parasitol 2004, 133:297-310.
28. Kinoshita Y, Jarell AD, Flaman JM, Foltz G, Schuster J, Sopher BL, Irvin DK, Kanning K, Kornblum HI, Nelson PS, et al: Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells. J Biol Chem 2001, 276:6656-6665.
29. Lerch-Gaggl A, Haque J, Li J, Ning G, Traktman P, Duncan SA: Pescadillo is essential for nucleolar assembly, ribosome biogenesis, and mammalian cell proliferation. J Biol Chem 2002, 277:45347-45355.
30. Hai T, Hartman MG: The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001, 273: 1-11.
31. Wang XZ, Lawson B, Brewer JW, Zinszner H, Sanjay A, Mi LJ, Boorstein R, Kreibich G, Hendershot LM, Ron D: Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol Cell Biol 1996, 16:4273-4280.
32. Aman P, Ron D, Mandahl N, Fioretos T, Heim S, Arheden K, Willen H, Rydholm A, Mitelman F: Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 1992, 5:278-285.
33. Forus A, Florenes VA, Maelandsmo GM, Fodstad O, Myklebost O: The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. Cancer Genet Cytogenet 1994, 78:165-171.
34. Yoshida H, Haze K, Yanagi H, Yura T, Mori K: Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J Biol Chem 1098, 273:33741-33749.
35. Haze K, Yoshida H, Yanagi H, Yura T, Mori K: Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 1999, 10:3787-3799.
36. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS: The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr 1994, 4:1-18.
37. Lee AS: The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 2001, 26:504-510.
38. Osoegawa K, Mammoser AG, Wu C, Frengen E, Zeng C, Catanese JJ, de Jong PJ: A bacterial artificial chromosome library for sequencing the complete human genome. Genome Res 2001, 11:483-496.
39. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP: DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 2003, 36:361-374.
40. Forus A, Florenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O: Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica, do not include MDM2. Cell Growth Differ 1993, 4:1065-1070.
41. Wang J, Meza-Zepeda LA, Kresse SH, Myklebost O: M-CGH: Analysing microarray-based CGH experiments. BMC Bioinformatics 2004, 5:74.
42. Lennon G, Auffray C, Polymeropoulos M, Soares MB: The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 1996, 33:151-152.
43. Rogne S, Myklebost O, Hoyheim B, Olaisen B, Gedde-Dahl TJ: The genes for apolipoprotein all (APOA2) and the Duffy blood group (FY) are linked on chromosome 1 in man. Genomics 1989, 4:169-173.
44. Huang LS, Bock SC, Feinstein SI, Breslow JL: Human apolipoprotein B cDNA clone isolation and demonstration that liver apolipoprotein B mRNA is 22 kilobases in length. Proc Natl Acad Sci U S A 1985, 82:6825-6829.
45. Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, et al: Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 2000, 118:89-98.
46. Parente F, Grosgeorge J, Coindre JM, Terrier P, Vilain O, Turc-Carel C: Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors. Cancer Genet Cytogenet 1999, 115:89-95.